Carine Patricia Seudieu Seudieu, USPTO Patent Examiner

Listed by the USPTO as SEUDIEU SEUDIEU, CARINE PATRICIA

Tech Center 1600 • Art Units: 1626

This examiner grants 0% of resolved cases

Performance Statistics

—

Allow Rate

-60.0% vs TC avg

Total Applications

—

Interview Lift

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

§101 Eligibility

20.0%

§102 Novelty

26.7%

§103 Obviousness

20.0%

§112 Clarity

App #	Title	Status	Assignee
18868614	COMBINATION TREATMENT FOR ADENOCARCINOMA	Non-Final OA	The General Hospital Corporation
18911340	BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF	Non-Final OA	Gilead Sciences, Inc.
18911404	BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF	Non-Final OA	Gilead Sciences, Inc.
18867416	METHODS OF TREATING SPINOCEREBELLAR ATAXIAS	Non-Final OA	Biohaven Therapeutics Ltd.
18868080	APROCITENTAN FOR THE TREATMENT OF HYPERTENSION	Non-Final OA	IDORSIA PHARMACEUTICALS LTD
18868353	COMPOUNDS AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM	Non-Final OA	IMBRIA PHARMACEUTICALS, INC.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Carine Patricia Seudieu Seudieu examines applications in Art Unit 1626 in Tech Center 1600 (Biotechnology & Pharmaceuticals).